[Clinical presentation, course and treatment of recurrent sarcoidosis: followup data].
The paper presents the results of long-term follow-ups of 107 patients with recurrent sarcoidosis registered as having Group VII-IB. In the patients, there was the greatest dissemination of the process in the lung, intrathoracic lymph nodes and other organs and MF MB in the blood, sputum, BAC? Group VIIIB patients need the greatest attention of physicians, treatment involving extracorporeal and physiotherapeutical methods to prevent respiratory failure and disability.
Ozerova
L V
LV
Rybakova
N P
NP
Zaĭtseva
I P
IP
Romanov
V V
VV
Mikheeva
L P
LP
Gedymin
L E
LE
Safonova
S G
SG
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D026741:Physical Therapy Modalities / Q000379:methods*; D010956:Plasmapheresis; D012008:Recurrence; D012074:Remission Induction; D012189:Retrospective Studies; D012507:Sarcoidosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D005938:Glucocorticoids